Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
DataMEDS AI, Inc. - SIC # 5122 - DRUGS, DRUG PROPRIETARIES, AND DRUGGISTS SUNDRIES
Ticker
Exchange
SIC #
Website
Latest Ticker
MEDS
Nasdaq
5122
datamedsai.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for DataMEDS AI, Inc.
DataMEDS AI Agrees to Acquire TBIA Cancer AI Blood Test Platform From Todos Medical Estate for Subsidiary Helomics, Inc.
- Nov 19th, 2026 2:11 pm
DataMeds AI Subsidiary Helomics, Inc. Announces Cancer Target Discovery and Anticancer Peptides Drug Development Partnership With DiaGen AI, Inc.
- Nov 18th, 2026 4:00 am
DataMeds AI Signs Preliminary Agreement With Florida Health Insurer for GLP-1 Patient Management App
- Nov 5th, 2026 4:49 am
DataMEDS AI Secures Supply Agreement for Six Compounded Peptides Following FDA Advisory Committee Recommendations
- Nov 2nd, 2026 4:42 am
DataMEDS AI Establishes "Health Lives Here" Community Respiratory Program for Corexa Health Pharmacy Network
- Oct 23rd, 2026 4:45 am
DataMeds Regains Compliance With NASDAQ Listing Standards
- Oct 20th, 2026 4:00 am
DataMeds AI Plans Peptide Compounding Expansion Through Corexa Health Following FDA Policy Proposal
- Oct 16th, 2026 4:56 am
DataMeds Applauds FDA's Proposed Interim Access Policy for Compounding Using Certain Peptides and Provides Corexa Health's Peptides Roadmap
- Oct 16th, 2026 4:00 am
DataMEDS Si Licenses U.S. Rights To Reboot Health AI's Direct-To-Consumer GLP-1 Weight Management Platform
- Oct 14th, 2026 7:48 am
DataMEDS SI Provides Business Update On CLIA Lab Helomics And Its Super Intelligence Predictive Oncology Division
- Oct 13th, 2026 10:11 am
DataMeds AI Announces Workforce Reductions as It Prioritises ChemoFx Cancer Diagnostic Test Commercialisation
- Oct 13th, 2026 5:02 am
DataMeds AI Secures Medicaid Coverage for ChemoFx Assay in Gynecologic Cancers
- Oct 12th, 2026 8:48 am
DataMEDS SI Announces Helomics Receives Medicaid Coverage Policy For Chemofx(R) Assay In Gynecologic Cancers
- Oct 12th, 2026 4:00 am
DataMeds AI Corexa Pharmacy Surpasses $1 Million in Monthly Revenue as Sales Rise 66%
- Oct 1st, 2026 8:05 am
DataMeds AI's Corexa Pharmacy Surpasses $1 Million In Monthly Revenue
- Oct 1st, 2026 4:00 am
Axe Compute Just Sold Its Cancer Business to Become an AI Stock
- Sep 28th, 2026 11:36 am
DataMeds AI Launches Health Lives Here App Focused on GLP-1 Telehealth and Pharmacy Services
- Sep 28th, 2026 9:02 am
DataMeds AI stock rises on health app launch
- Sep 28th, 2026 8:28 am
Scroll